MabCure Inc
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, In… Read more
MabCure Inc (MBCI) - Total Assets
Latest total assets as of December 2011: $4.81 Million USD
Based on the latest financial reports, MabCure Inc (MBCI) holds total assets worth $4.81 Million USD as of December 2011.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MabCure Inc - Total Assets Trend (2006–2011)
This chart illustrates how MabCure Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MabCure Inc - Asset Composition Analysis
Current Asset Composition (December 2011)
MabCure Inc's total assets of $4.81 Million consist of 3.3% current assets and 96.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $41.88K | 0.9% |
| Intangible Assets | $4.60 Million | 95.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2011)
This chart illustrates how MabCure Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MabCure Inc's current assets represent 3.3% of total assets in 2011, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 3.0% of total assets in 2011, down from 88.2% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 95.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is intangible assets at 95.7% of total assets.
MabCure Inc Competitors by Total Assets
Key competitors of MabCure Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen Topraysolar Co Ltd
SHE:002218
|
China | CN¥6.66 Billion |
|
JA Solar Technology Co Ltd
SHE:002459
|
China | CN¥105.38 Billion |
|
GCL System Integration Technology Co Ltd
SHE:002506
|
China | CN¥19.27 Billion |
|
Changzhou Almaden Co Ltd
SHE:002623
|
China | CN¥5.75 Billion |
|
Hainan Drinda Automotive Trim Co Ltd
SHE:002865
|
China | CN¥18.01 Billion |
|
Hanwha Solutions
KO:009830
|
Korea | ₩32.26 Trillion |
|
Hanwha Chemical Corp Pref
KO:009835
|
Korea | ₩32.26 Trillion |
|
Trive Property Group Bhd
KLSE:0118
|
Malaysia | RM126.77 Million |
MabCure Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MabCure Inc generates 0.10x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MabCure Inc is currently not profitable relative to its asset base.
MabCure Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.17 | 0.12 | 10.53 |
| Quick Ratio | 0.17 | 0.12 | 10.53 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-775.94K | $ -410.01K | $ 1.10 Million |
MabCure Inc - Advanced Valuation Insights
This section examines the relationship between MabCure Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.06 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -70.3% |
| Total Assets | $4.81 Million |
| Market Capitalization | $0.98 USD |
Valuation Analysis
Below Book Valuation: The market values MabCure Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: MabCure Inc's assets decreased by 70.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MabCure Inc (2006–2011)
The table below shows the annual total assets of MabCure Inc from 2006 to 2011.
| Year | Total Assets | Change |
|---|---|---|
| 2011-12-31 | $4.81 Million | -70.32% |
| 2010-12-31 | $16.21 Million | -14.42% |
| 2009-12-31 | $18.94 Million | -2.85% |
| 2008-12-31 | $19.49 Million | +38123.39% |
| 2006-12-31 | $51.00K | -- |